Fritz, G; Kaina, B
Rho GTPases: promising cellular targets for novel anticancer drugs.Curr Cancer Drug Targets. Bd. 6. H. 1. 2006 S. 1-14
Vodicka, P; Koskinen, M; Naccarati, A et al.
Styrene metabolism, genotoxicity and potential carcinogenicityDrug Metab Rev. Bd. 38. 2006 S. 805-53
Muhlhausen, U; Schirrmacher, R; Piel, M et al.
Synthesis of 131I-labeled glucose-conjugated inhibitors of O6-methylguanine-DNA methyltransferase (MGMT) and comparison with nonconjugated inhibitors as potential tools for in vivo MGMT imaging.J Med Chem. Bd. 49. H. 1. 2006 S. 263-72
Bockamp, Ernesto; Antunes, Cecilia; Maringer, Marko et al.
Tetracycline-controlled transgenic targeting from the SCL locus directs conditional expression to erythrocytes, megakaryocytes, granulocytes, and c-kit-expressing lineage-negative hematopoietic cellsBLOOD. Bd. 108. H. 5. 2006 S. 1533-1541
Schmidt, S; Debensason, D; Mühlan, H et al.
The DISABKIDS generic quality of life instrument showed cross-cultural validity.J Clin Epidemiol. Bd. 59. H. 6. 2006 S. 587-98
Schmidt, S; Mühlan, H; Power, M
The EUROHIS-QOL 8-item index: psychometric results of a cross-cultural field study.Eur J Public Health. Bd. 16. H. 4. 2006 S. 420-8
Köberle, B; Roginskaya, V; Wood, RD
XPA protein as a limiting factor for nucleotide excision repair and UV sensitivity in human cells.DNA Repair (Amst). Bd. 5. H. 5. 2006 S. 641-8
Cummings, M; Higginbottom, K; McGurk, CJ et al.
XPA versus ERCC1 as chemosensitising agents to cisplatin and mitomycin C in prostate cancer cells: role of ERCC1 in homologous recombination repair.Biochem Pharmacol. Bd. 72. H. 2. 2006 S. 166-75
Tsaryk, R; Fabian, K; Thacker, J et al.
XRCC2 deficiency sensitizes cells to apoptosis by MNNG and the alkylating anticancer drugs temozolomide, fotemustine and mafosfamideCancer Lett. Bd. 239. 2006 S. 305-313
Holtmann, M; Kaina, B; Poustka, F
Zytogenetische Veränderungen durch Methylphenidat?Z Kinder Jugendpsychiatr Psychother. Bd. 34. 2006 S. 215-220